Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis

ClinicalTrials.gov ID: NCT00071279

Public ClinicalTrials.gov record NCT00071279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Van Gogh-extension Trial, a Multicenter, International, Randomized, Double-blind, Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous SR34006 With Placebo in the Long-term Prevention of Symptomatic Venous Thromboembolism in Patients With Symptomatic Pulmonary Embolism or Deep-vein Thrombosis Who Completed 6 Months of Treatment With Vitamin K Antagonist or SR34006

Study identification

NCT ID
NCT00071279
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
1,215 participants

Conditions and interventions

Interventions

  • SR34006 (idraparinux sodium) Injection Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2003
Primary completion
Nov 30, 2005
Completion
Nov 30, 2005
Last update posted
Apr 5, 2011

2003 – 2005

United States locations

U.S. sites
32
U.S. states
11
U.S. cities
26
Facility City State ZIP Site status
Bay Pines VA Medical Center Bay Pines Florida
Pulmonary Associates of Brandon Brandon Florida
Jacksonville Cardiovascular Clinic Jacksonville Florida
Melbourne Internal Medicine Associates (MIMA) Melbourne Florida
Melbourne Internal Medical Associates (MIMA) Palm Bay Florida
Clinical Pharmacology Services Tampa Florida
Medical College of Georgia Augusta Georgia
Cardinal Bernardin Cancer Center Maywood Illinois
Loyola University Medical Center Maywood Illinois
Sinai Hospital of Baltimore Baltimore Maryland
Dr. Kiritkumar C. Patel's and Dr. Michele DeGregorio's Office Bloomfield Hills Michigan
Henry Ford Hospital Detroit Michigan
St. Joseph Mercy - Oakland Clinical Research Office Pontiac Michigan
St. Joseph Mercy - Oakland Pontiac Michigan
William Beaumont Hospital / Clinical Research Center Royal Oak Michigan
William Beaumont Hospital Troy Troy Michigan
Lovelace Sandia Health Systems, Clinical Thrombosis Center Albuquerque New Mexico
University of New Mexico Hospital Albuquerque New Mexico
Lehigh Valley Hospital Allentown Pennsylvania
Crozer-Chester Medical Center Upland Pennsylvania
Lung & Chest Medical Associates Spartanburg South Carolina
Spartanburg Pharmaceutical Research Spartanburg South Carolina
Spartanburg Regional Medical Center Spartanburg South Carolina
The Methodist Hospital Houston Texas
Scott and White Memorial Hospital and Clinic Temple Texas
The University of Texas Health Center at Tyler Tyler Texas
Inova Alexandria Hospital Alexandria Virginia
Pulmonary Associates of Fredericksburg, Inc. Fredericksburg Virginia
McGuire VA Medical Center Richmond Virginia
Swedish Medical Center Seattle Washington
Pulmonary Specialists/Spokane Respiratory Consultants Spokane Washington
Sacred Heart Medical Center Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00071279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00071279 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →